Navigation Links
Jan Marini Skin Research Suspends Sales of Popular Eyelash Products
Date:1/17/2008

SAN JOSE, Calif., Jan. 17 /PRNewswire/ -- Jan Marini Skin Research, Inc. (JMSR; http://www.janmarini.com) today announced that it will voluntarily suspend the sale of its Age Intervention Eyelash Conditioner and Age Intervention Masses of Lashes Mascara products in the U.S.

JMSR cited a patent infringement lawsuit by Allergan Pharmaceutical as one reason for the suspension. "We believe that it makes sense to suspend these products while we strategically review our options," said JMSR President & CEO Jan Marini. "We are assured that the Allergan allegations are unfounded. However, the lawsuit is a major distraction."

JMSR reasserted its confidence in the safety profile of the products, and noted that it has conducted numerous and excellent safety studies. The company maintains its legal right to market both products.

"While these two products have been overwhelmingly popular, JMSR's core skin care products remain the foundation of our business success," said Marini. "Our marketplace is incredibly loyal and supportive. We are preparing to launch new products and are very excited about 2008."

About Jan Marini Skin Research, Inc.

San Jose, CA-based Jan Marini Skin Research, Inc. is a recognized leader and innovator in skin care, providing state of the art technologies and breakthroughs in medically-based skin care therapies. JMSR Skin Care Management System is used and trusted by physicians and skin care professionals worldwide to ensure optimum results for their patients and clients. Products range from Glycolic Acid formulas and patented breakthroughs to the state-of-the-art anti-aging properties of the remarkable C-ESTA(R) family of products, all aimed at addressing aging skin, acne, rosacea and other common skin concerns. For more information, please visit http://www.janmarini.com

Contact: Megan Meece
'/>"/>

SOURCE Jan Marini Skin Research, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Jan Marini Skin Research Adds Two New Sheer Colors to Antioxidant Daily Face Protectant SPF 30 With PhytoMelanin(TM)
2. Jan Marini Skin Research Gives Familiar Logo a Facelift
3. Stanford researchers find culprit in aging muscles that heal poorly
4. Children of depressed moms do better when dad is involved, SLU researcher finds
5. UCLA researchers identify markers that may predict diabetes in still-healthy people
6. Mayo Clinic researchers discover new diagnostic test for detecting infection in prosthetic joints
7. New research shows how chronic stress worsens neurodegenerative disease course
8. New research explores newborn in-hospital weight loss
9. Research may unlock mystery of autisms origin in the brain
10. Bipolar disorder relapses halved by Melbourne researchers
11. HIVs impact in Zimbabwe explored in new research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2008)... New names and fresh websit... UME/GME administration software , ... one45 Software, a leading provider of healthcare ... of Cytiva Software Inc. (CRX:TSX.V), announced to...hcare education administration products., , ,Compl...
(Date:8/20/2008)... NEWTON, Mass., Aug. 20 /PRNewswire/ -- Questex M...o-business media company and owner of,American Spa... and the,International Beauty Shows, the Internati...) and the SPATEC appointment events today announce...stry portals SpaTrade (, http://www.SpaTrade.com ...
(Date:8/20/2008)... Survey Report Is Available at http://ww...Newswire/ -- A new survey released today,documents...re leveraging,health information technology (HIT) ...The survey results highlight the need for many HIT...dization and,interoperability to optimize clinical...
(Date:8/20/2008)...use postponed reproductive onset in teen, adult fe...EDNESDAY, Aug. 20 (HealthDay News) -- Alcoholism i...ccording to a study that compared women,s and men,... age when they had their first child. , The re...ian twins born between 1893-1964 (3,634 female and...
Breaking Medicine News(10 mins):Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 2Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 3Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 4Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 2Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 3Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 2Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 3Health News:Women's Alcohol Use Tied to Delayed Childbearing 2
...nversations with alleged lesbian pal deejay Samant... Girls' star kept in touch with her friends and re... magazine the access to the starlet's passionate c...n. In the conversations that appear under the tit...
...otect against the clustering of abnormal body chem... study in the Journal of Epidemiology and Communit...eased risk of diabetes, coronary artery disease, a...based on a representative sample of 2375 men aged ...
... Physicians (UK), the state of emergency services... audit entitled Myocardial Infarction National Aud...all in the percentage of people killed by heart at...wn 12.4 percent from last years figures, meaning 1...
...tion programs in low and middle-income countries, ...am unit costs to reduce . A UCSF-led team of rese... Other low and middle-income countries like Uganda... Russia were also assessed. "With the recent rep...
Other Medicine News:Health News:Survey Shows Emergency Services Of British Hospitals Doing A Good Job 2
(Date:8/14/2008)...Newswire-FirstCall/ -- Pharmasset, Inc.,(Nasdaq: ...mmitted to,discovering, developing and commerciali...ed unaudited financial results for the third fisca... a net loss attributable to,common stockholders of...he,quarter ended June 30, 2008, as compared to a n...
(Date:8/14/2008)...14 /- The Clinical Trials,Bootcamp an...hysicians,clinical coordinators, clinical researc...It will be held in Boca Raton at the Boca Resort f...inical coordinators, monitors and,other industry p...orporate,clinical trials into a practice, as well ...
(Date:8/14/2008)...begin in late 2008 or in early 2009 -, SAN CARLOS..., Inc.,(Nasdaq: NUVO ) today announced positive r... NU172, demonstrating that the direct thrombin,inh...tion with a rapid,return toward baseline after the... "NU172 has the potential to address many of the l...
(Date:8/13/2008)...-FirstCall/ -- As biotechnology,pharmaceutical an...cal,trials beyond their own borders to other parts...uth America, complicated regulatory environments,c...rding to an analysis by,Aon Corporation (NYSE: AO...those companies a visual representation of the com...
Breaking Medicine Technology:Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 2Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 3Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 4Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 5Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 6Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 7Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 8Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 9Nuvelo Announces Positive Phase 1b Proof-of-Concept Data With Anticoagulant NU172 2Nuvelo Announces Positive Phase 1b Proof-of-Concept Data With Anticoagulant NU172 3Nuvelo Announces Positive Phase 1b Proof-of-Concept Data With Anticoagulant NU172 4Aon: Complex Insurance Requirements, Risk Management Needs Challenge Firms Conducting Clinical Trials Beyond Own Borders 2Aon: Complex Insurance Requirements, Risk Management Needs Challenge Firms Conducting Clinical Trials Beyond Own Borders 3Aon: Complex Insurance Requirements, Risk Management Needs Challenge Firms Conducting Clinical Trials Beyond Own Borders 4Consumers Health Care Purchasers Applaud Agreement On Physician Performance Reporting 4851 1Consumers Health Care Purchasers Applaud Agreement On Physician Performance Reporting 4851 2Consumers Health Care Purchasers Applaud Agreement On Physician Performance Reporting 4851 3Consumers Health Care Purchasers Applaud Agreement On Physician Performance Reporting 4851 4Dead clams tell many tales 1007 1Dead clams tell many tales 1007 2Dead clams tell many tales 1007 3Dead clams tell many tales 1007 4Tiny radioactive spheres effectively treat cancer that has spread to the liver 4844 1Tiny radioactive spheres effectively treat cancer that has spread to the liver 4844 2New treatment option studied for bladder cancer 4839 1New treatment option studied for bladder cancer 4839 2New treatment option studied for bladder cancer 4839 3
...curs at the 55th Annual,Clinical Meeting of the Am... COLLEGEVILLE, Pa., May 09, 2007 /PRNewswire-First...h , presented results from the,first Phase 3 studi... treatment of moderate-to-severe vasomotor symptom...enopause. These studies showed,that women who took...
...- Results of a Phase 2a,clinical trial evaluating ...eat hospital acquired gram-negative bacterial,pneu...ociety (ATS),International Conference, May 18 - 23...S. Niederman, MD, Chairman, Department of, ...or of, Medicine; Vice Chairman, Departme...
Other Medicine Technology:Wyeth Presents Phase 3 Data for Pristiq, an Investigational,Non-Hormonal Therapy for Menopausal Hot Flashes and Night Sweats 2Wyeth Presents Phase 3 Data for Pristiq, an Investigational,Non-Hormonal Therapy for Menopausal Hot Flashes and Night Sweats 3Wyeth Presents Phase 3 Data for Pristiq, an Investigational,Non-Hormonal Therapy for Menopausal Hot Flashes and Night Sweats 4Wyeth Presents Phase 3 Data for Pristiq, an Investigational,Non-Hormonal Therapy for Menopausal Hot Flashes and Night Sweats 5Wyeth Presents Phase 3 Data for Pristiq, an Investigational,Non-Hormonal Therapy for Menopausal Hot Flashes and Night Sweats 6Clinical Trial Data (Phase 2a) Regarding Inhaled Amikacin Will Be,Presented at American Thoracic Society International Conference 2Clinical Trial Data (Phase 2a) Regarding Inhaled Amikacin Will Be,Presented at American Thoracic Society International Conference 3
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
Medicine Products: